Author Correction: Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system
Philipp A. Ilinykh(Houston Methodist), Alexander Bukreyev(Galveston College), Robert H. Carnahan(Vanderbilt University Medical Center), Natalia A. Kuzmina(Galveston College), Kai Huang(Galveston College), Pavlo Gilchuk(AstraZeneca (Japan)), Matthew A. Hyde(Galveston College), Chandru Subramani(Galveston College), Lauren E. Williamson(Vanderbilt University Medical Center), Galit Alter(Ragon Institute of MGH, MIT and Harvard), James E. Crowe(Vanderbilt University Medical Center), Fuchun Zhou(Capital Medical University), Jalene V. Velazquez(Washington State University), Bronwyn M. Gunn(Washington State University), Eduardo Jurado-Cobena(The University of Texas Medical Branch at Galveston), Kritika Kedarinath(Galveston College)
Cited by 0
Related Papers
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|Nature Medicine|2020|543
Taxonomy of the order Mononegavirales: update 2016
|Archives of Virology|2016|506